International Journal of Osteopathic Medicine
Volume 12, Issue 4 , Pages 115-120 , December 2009

Masterclass: HIV-infection and osteopathy

Received 2 April 2009 ,Accepted 15 April 2009.

References 

  1. Unaids W. AIDS epidemic update: December 2007. Geneva: Joint UN Programme on HIV/AIDS, World Health Organization; 2007;
  2. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 372: p. 293–9.
  3. UK Collaborative Group for HIV and STI Surveillance. HIV in the United Kingdom: 2008 Report. London, United Kingdom: Health Protection Agency.
  4. AVERT, AIDS & HIV in the UK; 2009.
  5. Mocroft A, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352:1725–1730
  6. O'Neill J, Selwyn P, Schietinger H. A Clinical Guide to Supportive and Palliative Care for HIV/AIDS. Washington: US Department of Health and Human Sciences, HIV/AIDS Bureau; 2003;
  7. Harding R, Molloy T, Easterbrook P, Frame K, Higginson I. Is antiretroviral therapy associated with symptom prevalence and burden?. Int J STD AIDS. 2006;17:400
  8. Silverberg M, Gore ME, French A, Gandhi M, Glesby MJ, Kovacs A, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the women's interagency HIV study. Clin Infect Dis. 2004;39(5):717–724
  9. Martin C, Pehrsson P, Österberg A, Sönnerborg A, Hansson P. Pain in ambulatory HIV-infected patients with and without intravenous drug use. Eur J Pain. 1999;3(2):157–164
  10. Tsao J, Dobalian A, Myers CD, Zeltzer LK. Pain and use of complementary and alternative medicine in a national sample of persons living with HIV. J Pain Symptom Manage. 2005;30(5):418–432
  11. Simmonds M, Novy D, Sandoval R. The differential influence of pain and fatigue on physical performance and health status in ambulatory patients with human immunodeficiency virus. Clin J Pain. 2005;21(3):200
  12. Vogl D, Rosenfeld B, Breitbart W, Thaler H, Passik A, McDonald M, et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage. 1999;18(4):253–262
  13. Frich L, Borgbjerg F. Pain and pain treatment in AIDS patients: a Longitudinal Study. J Pain Symptom Manage. 2000;19(5):339–347
  14. Dobalian A, Tsao J, Duncan R. Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey. Med Care. 2004;42(2):129
  15. Holzemer W, Henry S, Reilly C. Assessing and managing pain in AIDS care: the patient perspective. J Assoc Nurses AIDS Care. 1998;9(1):22–30
  16. Bernard N, Spira R, Ybanez S, Chône P, Morlat P, Lacoste D, et al. Prevalence and underestimation of pain in HIV-infected patients by physicians: a cross-sectional study in a day care hospital. AIDS. 1999;13(2):293
  17. Hewitt D, McDonald M, Portenoy RK, Rosenfeld B, Passik S, Breitbart W. Pain syndromes and etiologies in ambulatory AIDS patients. Pain (Amsterdam). 1997;70(2–3):117–123
  18. Karus D, Raveis VH, Alexander C, Hanna B, Selwyn P, Marconi K, et al. Patient Reports of Symptoms and Their Treatment at Three Palliative Care Projects Servicing Individuals with HIV/AIDS. J Pain Symptom Manage. 2005;30(5):408–417
  19. Sullivan P, Dworkin M, Adult and Adolescent Spectrum of HIV Disease Investigators . Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage. 2003;25(4):329–333
  20. Crystal S, Fleishman JA, Hays RD, Shapiro MF, Bozzette SA. Physical and role functioning among persons with HIV: results from a nationally representative survey. Med Care. 2000;38(12):1210
  21. Anderson W, Weatherburn P. The needs of people with HIV in the UK: findings from a national survey. Int J STD AIDS. 2004;15(12):793
  22. Green G, Smith R. The psychosocial and health care needs of HIV-positive people in the United Kingdom: a review. HIV Med. 2004;5(s1):4–46
  23. Gonzalez J, Penedo FJ, Llabre MM, Durán RE, Antoni MH, Schneiderman N, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34(1):46–55
  24. Bozzette S, Ake CF, Tam HK, Phippard A, Cohen D, Scharfstein DO, et al. Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47(3):338
  25. Hammer S, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300(5):555
  26. Gazzard B. British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008;9(8):563–608
  27. Briere J, Elliott D. Prevalence and psychological sequelae of self-reported childhood physical and sexual abuse in a general population sample of men and women. Child Abuse Negl. 2003;27(10):1205–1222
  28. Brady S, Gallagher D, Berger J, Vega M. Physical and sexual abuse in the lives of HIV-positive women enrolled in a primary medicine health maintenance organization. AIDS Patient Care STDs. 2002;16(3):121–125
  29. Liebschutz J, Feinman G, Sullivan L, Stein M, Samet J. Physical and Sexual abuse in women infected with the human immunodeficiency virus increased illness and health care utilization, in Archives of Internal Medicine. Am Med Assoc. 2000;1659–1664
  30. Kalichman S, Sikkema KJ, DiFonzo K, Luke W, Austin J. Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma stress. 2002;15(4):
  31. Zierler S. Violence victimization after HIV infection in a US probability sample of adult patients in primary care, in American Journal of Public Health. Am Public Health Assoc. 2000;208–215
  32. Sowell R, Phillips KD, Seals B, Murdaugh C, Rush C. Incidence and correlates of physical violence among HIV-infected women at risk for pregnancy in the southeastern United States. J Assoc Nurses AIDS Care: JANAC. 13(2): p. 46.
  33. Schachter C, Stalker C, Teram E. Toward sensitive practice: Issues for physical therapists working with survivors of childhood sexual abuse. Phys Ther. 1999;79(3):248
  34. Franklin C. Physiotherapy with torture survivors. Physiotherapy-London. 2001;87(7):374–377
  35. Bing E, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States, in Archives of General Psychiatry. Am Med Assoc. 2001;721–728
  36. Lefevre F, O'Leary B, Moran M, Mossar M, Yarnold PR, Martin GJ, et al. Alcohol consumption among HIV-infected patients. J Gen Int Med. 1995;10(8):458–460
  37. Petry N. Alcohol use in HIV patients: what we don't know may hurt us. Int J STD AIDS. 1999;10(9):561
  38. Linley P, Joseph S. Positive change following trauma and adversity: a review. J Trauma Stress. 2004;17(1):11–21
  39. Milam J. Posttraumatic growth among HIV/AIDS patients 1. J Appl Soc Psychol. 2004;34(11):2353–2376
  40. Kraaij V, van der Veek SMC, Garnefski N, Schroevers M, Witlox R, Maes S, et al. Coping, goal adjustment, and psychological well-being in HIV-infected men who have sex with men. AIDS Patient Care STDs. 2008;22(5):395–402
  41. Blanchard PD. A descriptive account of the development of an osteopathic service within a hospital HIV day care centre. Int J Osteopath Med. 2009;12(3):97–99
  42. Tien P, Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis. 2004;17(1):27
  43. Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E. HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms. AIDS Res Ther. 2007;4(1):14
  44. Kotler D. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;49:S79
  45. Cheung Y, Doyley M, Miller TB, Kennedy F, Lynch F, Wrobel JS, et al. Magnetic resonance elastography of the plantar fat pads: preliminary study in diabetic patients and asymptomatic volunteers. J Comput Assist Tomogr. 2006;30(2):321
  46. Stupar M, Tibbles A. Heel pain and HIV-associated lipodystrophy: a report of two cases. J Can Chiropr Assoc. 2008;52(2):103
  47. Kao PF, Davis BL, Hardy PA. Characterization of the calcaneal fat pad in diabetic and non-diabetic patients using magnetic resonance imaging. Magn Reson Imaging. 1999;17(6):851–857
  48. O'Sullivan P, Twomey L, Allison G, Sinclair J, Miller K. Altered patterns of abdominal muscle activation in patients with chronic low back pain. Aust J Physiother. 1997;43(2):91–98
  49. Blanchard P. Diastasis recti abdominis in HIV-infected men with lipodystrophy. HIV Med. 2005;6(1):54–56
  50. Dong K, Bausserman LL, Flynn MM, Dickinson BP, Flanigan TP, Mileno MD, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr. 1999;21(2):107
  51. Woolley I, Mijch AM, Carter VM, Archer B, Hoy JF. Anterior neck fat deposition in lipodystrophy syndrome; a new variant on a theme?. AIDS. 2003;17(12):1857
  52. Gold D, Annino D. HIV-associated cervicodorsal lipodystrophy: etiology and management. Laryngoscope. 2005;115(5):791
  53. Lo Re V, Schutte-Rodin S, Kostman J. Obstructive sleep apnoea among HIV patients. Int J STD AIDS. 2006;17(9):614
  54. Schulz R. Obstructive sleep apnea due to HIV-associated lipodystrophy. Clin Infect Dis. 2003;1398–1399
  55. Jacobson D, Spiegelman D, Knox TK, Wilson IB. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr. 2008;49(3):298
  56. Morse C, Mican JAM, Jones EC, Joe GO, Rick ME, Formentini E, et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis. 2007;44(5):739–748
  57. Brown T, Qaqish R. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17):2165
  58. Miller K, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Annals of Internal Medicine. 2002;137(1):17–25
  59. Gonzalez-Duarte A, Robinson-Papp J, Simpson D. Diagnosis and management of HIV-associated neuropathy. Neurol Clin. 2008;26(3):821–832
  60. Hoke A, Cornblath D. Peripheral neuropathies in human immunodeficiency virus infection. Suppl Clin Neurophysiol. 2004;57:195–210
  61. McArthur J, Brew B, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4(9):543–555
  62. Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy The Manhattan HIV Brain Bank, in Archives of Neurology. Am Med Assoc. 2004;546–551
  63. van Schie CH. A review of the biomechanics of the diabetic foot. Int J Low Extrem Wounds. 2005;4(3):160–170
  64. Simmons RW, Richardson C, Deutsch K. Limited joint mobility of the ankle in diabetic patients with cutaneous sensory deficit. Diabetes Res Clin Pract. 1997;37(2):137–143
  65. Salsich GB, Mueller MJ, Sahrmann SA. Passive ankle stiffness in subjects with diabetes and peripheral neuropathy versus an age-matched comparison group. Phys Ther. 2000;80(4):352–362
  66. Payne CB. Biomechanics of the foot in diabetes mellitus. Some theoretical considerations. J Am Podiatr Med Assoc. 1998;88(6):285–289
  67. Klaesner JW, Hastings MK, Zou D, Lewis C, Mueller MJ. Plantar tissue stiffness in patients with diabetes mellitus and peripheral neuropathy. Arch Phys Med Rehabil. 2002;83(12):1796–1801
  68. Goldsmith JR, Lidtke RH, Shott S. The effects of range-of-motion therapy on the plantar pressures of patients with diabetes mellitus. J Am Podiatr Med Assoc. 2002;92:483–490
  69. Glasoe WM, Allen MK, Ludewig PM, Saltzman CL. Dorsal mobility and first ray stiffness in patients with diabetes mellitus. Foot Ankle Int. 2004;25:550–555
  70. Giacomozzi C, D'Ambrogi Emanuela, Cesinaro Stefano, Macellari Velio, Uccioli Luigi. Muscle performance and ankle joint mobility in long-term patients with diabetes. BMC Musculoskelet Disord. 2008;99
  71. Frost D, Beischer W. Limited joint mobility in type 1 diabetic patients: associations with microangiopathy and subclinical macroangiopathy are different in men and women. Diabetes Care. 2001;24:95–99
  72. Duffin AC, Donaghue KC, Potter M, McInnes A, Chan AK, King J, et al. Limited joint mobility in the hands and feet of adolescents with type 1 diabetes mellitus. Diabet Med. 1999;16:125–130
  73. Dijs HM. Effect of physical therapy on limited joint mobility in the diabetic foot. A pilot study. J Am Podiatr Med Assoc. 2000;90:126–132
  74. Campbell RR, Hawkins SJ, Maddison PJ, Reckless JP. Limited joint mobility in diabetes mellitus. Ann Rheum Dis. 1985;44:93–97
  75. Arkkila PE, Kantola IM, Viikari JS. Limited joint mobility in non-insulin-dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications. J Diabetes Complications. 1997;11:208–217
  76. Expert Advisory Group on AIDS . Guidance for clinical health care workers: protection against infection with blood-borne viruses: recommendations of the Expert Advisury Group on AIDS and the Advisory group on Hepatitis. UK Department of Health, HMSO; 1998;
  77. Mahajan A, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22:S67
  78. Mercier C, Haig L. Infection control in physiotherapy. Physiotherapy. 1993;79:385–387

☆ Sources of support: Elton John AIDS Foundation and the Peter Moores Foundation.

PII: S1746-0689(09)00043-1

doi: 10.1016/j.ijosm.2009.04.001

International Journal of Osteopathic Medicine
Volume 12, Issue 4 , Pages 115-120 , December 2009

Article Tools